3. Wang YH, Wang DR, Liu JY, Pan J. Local anesthesia in oral and maxillofacial surgery: a review of current opinion. J Dent Sci. 2021;16(4):1055-1065.
4. Carrasco-Labra A, Polk DE, Urquhart O, et al. Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults: a report from the American Dental Association Science and Research Institute, the University of Pittsburgh, and the University of Pennsylvania. J Am Dent Assoc. 2024;155(2)102-117.
5. Forster VJ, Bell G, Halsey C. Should nitrous oxide ever be used in oncology patients receiving methotrexate therapy? Paediatr Anaesth. 2020;30(1):9-16.
6. Federal Register. Content and Format of Labeling for Human Prescription Drug and Biological Products: Requirements for Pregnancy and Lactation Labeling. Available at https://www.federalregister.gov/articles/2014/12/04/2014-28241/content-andformat-of-labeling-for-human-prescription-drug-and-biological-products-requirements-for. Last accessed August 1, 2024.
7. LexiDrug. Available at https://online.lexi.com. Last accessed August 1, 2024.
8. Federal Register. Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products—Content and Format; Draft Guidance for Industry; Availability. Available at https://www.federalregister.gov/documents/2020/07/30/2020-16530/pregnancy-lactation-and-reproductive-potential-labeling-for-human-prescription-drug-and-biological. Last accessed August 20, 2021.
10. Uckan S, Dayangac E, Araz K. Is permanent maxillary tooth removal without palatal injection possible? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(6):733-735.
11. Yadav S. Anesthetic success of supplemental infiltration in mandibular molars with irreversible pulpitis: a systematic review. J Conserv Dent. 2015;18(3):182-186.
12. Ashraf H, Kazem M, Dianat O, Noghrehkar F. Efficacy of articaine versus lidocaine in block and infiltration anesthesia administered in teeth with irreversible pulpitis: a prospective, randomized, double-blind study. J Endod. 2013;39(1):6-10.
13. Parirokh M, Yosefi MH, Nakhaee N, Abbott PV, Manochehrifar H. The success rate of bupivacaine and lidocaine as anesthetic agents in inferior alveolar nerve block in teeth with irreversible pulpitis without spontaneous pain. Restor Dent Endod. 2015;40(2):155-160.
14. Pogrel MA. Permanent nerve damage from the inferior alveolar nerve blocks: an update to include articaine. J Calif Dent Assoc. 2007;35(4):271-273.
15. Pogrel MA, Permanent nerve damage from inferior alveolar nerve blocks: a current update. J Calif Dent Assoc. 2012;40(10):795-797.
16. Kakroudi SH, Mehta S, Millar BJ. Articaine hydrochloride: is it the solution? Dent Update. 2015;42(1):88-90.
17. Mayo Clinic. Periodontitis. Available at https://www.mayoclinic.org/diseases-conditions/periodontitis/symptoms-causes/syc-20354473. Last accessed August 1, 2024.
18. Centers for Disease Control and Prevention. Clinical Overview of Invasive Candidiasis. Available at https://www.cdc.gov/candidiasis/hcp/clinical-overview/index.html. Last accessed August 1, 2024.
19. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.
20. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA Limits Usage of Nizoral (ketoconazole) Oral Tablets Due to Potentially Fatal Liver Injury and the Risk of Drug Interactions and Adrenal Gland Problems. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially. Last accessed August 1, 2024.
21. World Health Organization. WHO Model List of Essential Medicines. Available at https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists. Last accessed August 1, 2024.
22. Little JW, Miller CS, Rhodus NL. Little and Falace's Dental Management of the Medically Compromised Patient. 10th ed. St. Louis, MO: Mosby; 2023.
23. Yaksh T, Wallace M. Section II: Neuropharmacology. Chapter 20: Opioids, Analgesia, and Pain Management. In: Brunton LL, Hilal-Dandan R, Knollmann BC (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics. 13th ed. New York, NY: McGraw-Hill; 2018.
24. Goerig M, Schulte am Esch J. History of nitrous oxide with special reference to its early use in Germany. Best Pract Res Clin Anesthesiol. 2001;15(3):313-338.
25. Dental Assisting National Board, Inc. California State Requirements. Additional Resources: Allowable and Prohibited Duties for Each Level (PDF). Available at https://www.danb.org/Meet-State-Requirements/State-Specific-Information/California.aspx. Last accessed August 1, 2024.
26. Khouja T, Shh NH, Suda KJ, Polk DE. Trajectories of opioid prescribing by general dentists, specialists, and oral and maxillofacial surgeons in the United States, 2015–2019. JADA. 2024;155(1):7-16.
27. McCauley JL, Leite RS, Gordan VV, et al. Opioid prescribing and risk mitigation implementation in the management of acute pain: results from The National Dental Practice-Based Research Network. JADA. 2018;149(5):353-362.
28. McCauley JL, Leite RS, Melvin CL, Fillingim RB, Brady KT. Dental opioid prescribing practices and risk mitigation strategy implementation: identification of potential targets for provider-level intervention. Subst Abus. 2016;37(1):9-14.
29. PubChem Compound. Penicillin V. Available at https://pubchem.ncbi.nlm.nih.gov/compound/6869. Last accessed August 1, 2024.
30. Topazian RG, Goldberg MH, Hupp JR (eds). Oral and Maxillofacial Infections. 4th ed. Philadelphia, PA: WB Saunders; 2002.
31. The Merck Manual. Lincosamides, Oxazolidinones, and Streptogramins. Available at https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/lincosamides%2C-oxazolidinones%2C-and-streptogramins. Last accessed August 1, 2024.
32. Gross AE, Hanna D, Rowan SA, Bleasdale SC, Suda KJ. Successful implementation of an antibiotic stewardship program in an academic dental practice. Open Forum Infect Dis. 2019;6(3):1-6.
33. Suda KJ, Henschel H, Patel U, Fitzpatrick MA, Evans CT. Use of antibiotic prophylaxis for tooth extractions, dental implants, and periodontal surgical procedures. Open Forum Infect Dis. 2018;5(1):1-5.
34. Loffler C, Bohmer F. The effect of interventions aiming to optimize the prescription of antibiotics in dental care: a systematic review. PLoS One. 2017;12(11):1-23.
35. Lockhart PB, Tampi MP, Abt E, et al. Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling: a report from the American Dental Association. JADA. 2019;150(11):906-921.
36. Centers for Disease Control and Prevention. Antibiotic/Antimicrobial Resistance (AR/AMR): The AMR Challenge. Available at https://archive.cdc.gov/www_cdc_gov/drugresistance/us-activities/amr-challenge.html. Last accessed August 1, 2024.
38. Mailänder-Sánchez D, Wagener J, Schaller M. Potential role of probiotic bacteria in the treatment and prevention of localised candidosis. Mycoses. 2012;55(1):17-26.
39. The American Dental Association. Antibiotic Prophylaxis Prior to Dental Procedures. Available at https://www.ada.org/resources/ada-library/oral-health-topics/antibiotic-prophylaxis. Last accessed August 28, 2024.
40. Medical Wellness Center. Frequently Asked Questions: Periostat. Available at https://www.medicalwellnesscenter.com/Periostatquestionsandanswers.htm. Last accessed August 20, 2024.
1. American Dental Association. Guidelines for the Use of Sedation and General Anesthesia by Dentists. Chicago, IL: American Dental Association; 2007. Available at https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/research/ada_sedation_ use_guidelines.pdf. Last accessed August 22, 2024.
Mention of commercial products does not indicate endorsement.